about
Myocardin is a critical serum response factor cofactor in the transcriptional program regulating smooth muscle cell differentiation.GATA-5: a transcriptional activator expressed in a novel temporally and spatially-restricted pattern during embryonic developmentGATA6 regulates HNF4 and is required for differentiation of visceral endoderm in the mouse embryoGATA4 transcription factor is required for ventral morphogenesis and heart tube formationMyocardin is required for cardiomyocyte survival and maintenance of heart functionHypercholesterolemia suppresses Kir channels in porcine bone marrow progenitor cells in vivo.Engineered chromosome-based genetic mapping establishes a 3.7 Mb critical genomic region for Down syndrome-associated heart defects in miceMyocardin-related transcription factor B is required in cardiac neural crest for smooth muscle differentiation and cardiovascular development.Transcriptional programs regulating vascular smooth muscle cell development and differentiation.MRL mice fail to heal the heart in response to ischemia-reperfusion injury.An essential role for Notch in neural crest during cardiovascular development and smooth muscle differentiation.Cardiomyocyte renewal.Genetic analysis of Down syndrome-associated heart defects in mice.Aortic aneurysm generation in mice with targeted deletion of integrin-linked kinase in vascular smooth muscle cellsBiology of the troponin complex in cardiac myocytes.Myocardin-like protein 2 regulates TGFβ signaling in embryonic stem cells and the developing vasculature.GATA-6 promotes cell survival by up-regulating BMP-2 expression during embryonic stem cell differentiationMyocardin-related transcription factors: critical coactivators regulating cardiovascular development and adaptation.Transcriptional targeting of replication-defective adenovirus transgene expression to smooth muscle cells in vivo.MicroRNA-modulated targeting of vascular smooth muscle cells.Binding of serum response factor to CArG box sequences is necessary but not sufficient to restrict gene expression to arterial smooth muscle cells.Diabetes reduces bone marrow and circulating porcine endothelial progenitor cells, an effect ameliorated by atorvastatin and independent of cholesterol.Oxidative stress modulates vascular smooth muscle cell phenotype via CTGF in thoracic aortic aneurysm.A Gata6-Wnt pathway required for epithelial stem cell development and airway regeneration.Modulation of smooth muscle cell phenotype: the other side of the story.Myocardin-related transcription factor-A: mending a broken heartSecreted miRNAs suppress atherogenesis.SM22beta encodes a lineage-restricted cytoskeletal protein with a unique developmentally regulated pattern of expression.Myocardin: dominant driver of the smooth muscle cell contractile phenotype.Endothelial-mesenchymal interactions in vitro reveal molecular mechanisms of smooth muscle/pericyte differentiation.Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product.Ablation of SM22alpha decreases contractility and actin contents of mouse vascular smooth muscle.Structure and expression of a smooth muscle cell-specific gene, SM22 alpha.Protein synthesis and degradation during starvation-induced cardiac atrophy in rabbits.Effect of acute exercise on endothelial progenitor cells in patients with peripheral arterial disease.Adenovirus-catheter compatibility increases gene expression after delivery to porcine myocardiumA novel ultrasound method for evaluation of collateral development in limb ischemiaMyocardin--not quite MyoDHigh-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22alpha-Cre transgenic mice
P50
Q24297859-3F630C7E-F856-4B06-A6A1-B3C3256AC1B6Q28505891-850171CB-E6CE-4F60-9CE6-C7A8BA4A1930Q28506998-DDC87EE1-D808-418C-A908-953F89EF59C0Q28586495-281F186F-7650-4AEF-8349-D37FCCC4ACC3Q28588163-84B34E7A-6EED-4CE3-92F3-02F1BCAA6A08Q33283815-99549C03-3DC7-4C26-9DD8-97AA65AAA54AQ33624012-D0511AAA-BC5F-499F-8F42-2EE0A6C37318Q33863289-160CC4D0-236B-4165-B14C-63E580ED5DC4Q34173691-B0DAC704-0B9A-4F42-A1A9-C9D94E84CCB0Q34411234-27A03E02-B34C-474D-A40C-A46F46344859Q34608845-F51D57BC-F94B-4ABC-8D0C-ADB2E9DC2075Q34990218-BB8263BF-8A9A-4A01-8722-44B6ABFC17CDQ35669274-3B989444-2FB5-4EBC-97D6-DD429E962D1EQ35956150-D5B0A7C1-5698-43A3-ADF0-36BF71AE9C33Q36057095-992408C6-8D47-4F2D-8234-316877CB1C5EQ36215741-D379818F-0B90-424B-9272-DA64250A69E9Q36234535-07289D14-8D35-4231-B196-AE648AE6DCDCQ36761045-0FB4E7A8-0FE0-404E-AEE0-9AD04F0750B2Q37371503-1EAE5F65-1965-4158-B84D-A83BBE704A1EQ39954283-7FBD5E47-EF9E-4E3D-91E9-24863561DAA0Q40816362-E532B7D5-B097-4AEF-8FA3-F67306E2F885Q41896798-64D82D3B-1F8D-4C1D-AB25-368F1A501874Q42058334-50E10862-F53F-40B3-847D-A648A077A5A3Q42143150-59348F8B-C749-415E-9839-733634C8E77FQ42324593-3A72BDCB-4B63-4203-A56D-57086CDE2C9FQ42569792-6C556CF1-ED64-450C-A6F0-DCCFF0460A3CQ42749213-2CC643FC-CF11-49CC-9043-EC0147C0554EQ42814355-34E4AF92-B53D-4772-9106-88C015347EC0Q43190559-3FD708CD-2E59-4332-9D6A-95023ADF4395Q45180253-BA711B6E-25BF-42F9-85AD-B6E1E9489510Q45869776-6AA12475-D94E-48F8-BF80-1817FC9B5BBEQ47883970-059DCF73-2CA4-4B11-83DB-C6E8F1D908E3Q48072982-7BFA1092-3AD7-4F2D-8F9C-1FB69805B8BCQ51629471-3ABAA618-D634-4486-9ADB-2D7C02A3B4F5Q53563103-361951BE-1735-4239-9706-A464E62FACBEQ64377941-8330ED56-354E-41FE-BC95-1A9DD5D1AFC3Q78849446-4DE4923C-F6D0-44CC-8FF2-FC5BC288F493Q80522079-6BC8E6B7-6D50-4C0B-9DAE-5218D215F1A1Q81571825-CA89B093-361A-465F-81AD-1CE56CF32795
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Michael S Parmacek
@ast
Michael S Parmacek
@en
Michael S Parmacek
@es
Michael S Parmacek
@nl
Michael S Parmacek
@sl
type
label
Michael S Parmacek
@ast
Michael S Parmacek
@en
Michael S Parmacek
@es
Michael S Parmacek
@nl
Michael S Parmacek
@sl
prefLabel
Michael S Parmacek
@ast
Michael S Parmacek
@en
Michael S Parmacek
@es
Michael S Parmacek
@nl
Michael S Parmacek
@sl
P106
P21
P31
P496
0000-0003-1449-4665